CDC Recommends Second COVID-19 Vaccine Dose for Seniors and Immunocompromised Individuals

Atlanta — The Centers for Disease Control and Prevention (CDC) has issued a recommendation for a second dose of the 2024-2025 COVID-19 vaccine for individuals aged 65 and older, along with people who are moderately or severely immunocompromised. CDC Director Mandy Cohen endorsed the recommendation from the CDC’s Advisory Committee on Immunization Practices (ACIP). The ACIP met to review current data and make recommendations regarding vaccine usage. The recommendation advises that eligible individuals receive the second dose six months after their initial 2024-2025 vaccine dose. The CDC stated this updated guidance aims to provide enhanced protection against COVID-19 for those at higher risk of severe illness. Information regarding vaccine availability and specific eligibility criteria can be found on the CDC website and through local healthcare providers.